|Articles|January 24, 2017

New Partnership to Provide Co-Pay Assistance Programs to Consumers

January 20, 2017

GoodRx (Santa Monica, CA) and Triplefin (Cincinnati, OH), a  provider of pharmaceutical hub services, have partnered to provide manufacturer prescription co-pay savings coupons to GoodRx’s five million unique monthly visitors.

Access to prescription drugs is a longstanding an issue for uninsured and underinsured Americans. The GoodRx-Triplefin partnership will reportedly provide pharmaceutical brand manufacturers with a premium and focused channel to reach cost-conscious consumers as they search for pricing information for branded medications.

“Branded medications are often associated with high out-of-pocket costs for consumers,” said Doug Hirsch, co-founder and co-CEO of GoodRx. “With this new and innovative partnership, we are continuing our mission to make prescriptions more affordable for all Americans. We look forward to working with Triplefin to provide patients with the information they need to make better choices when it comes to their healthcare.” 

 

 

 


Related to this article

How QMM Can Help the C-Suite See a  $100 Million Problem Early
A passing FDA inspection tells pharma senior leadership very little about whether the next significant revenue vulnerability is already taking shape. But continuous, AI-enabled quality management maturity (QMM) has the potential to do so months before the issue reaches the realm of P&L.